Drugs / Pentastarch
Pentastarch
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT00474162 | May 2007 → Feb 2008 | — | University of British Columbia | Completed | No outcome recorded |
| — | NCT00182377 | — | — | Hamilton Health Sciences Corporation | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01512628 Comparator | Jan 2012 → Dec 2013 | avascular necrosis | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pentastarch | “The starch solution used at BC Women's Hospital is called pentastarch and no research has looked at its effect on clotting in pregnant women.” NCT00474162 ↗ |
| Known as | ASL-607 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108122 ↗ |
| Known as | Infukoll | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108122 ↗ |
| Known as | Pentaspan | “The use of Pentaspan - a synthetic pentastarch - was started because of the restriction of use for blood and blood products, particularly albumin.” NCT00182377 ↗ |
| Route | Intravenous | “the remainder of the study solution will be given very rapidly over 10 minutes into the vein” NCT00474162 ↗ |